Sustained Low Clinical Event Rates in Real-World Patients Receiving Everolimus-Eluting Coronary Stent System from a Large, Prospective, Condition of Approval Study: 2-Year Clinical Outcomes from the XIENCE V®USA Study
2012 ◽
Vol 25
(6)
◽
pp. 565-575
◽
Keyword(s):